For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of Vyndamax and Attruby represents a true breakthrough . These groundbreaking therapies protect the transthyretin protein, preventing its harmful build-up and alleviating the severity of the condition . Patients are now seeing benefits … Read More